Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients
References (31)
- et al.
The importance of cytogenetic studies in adult acute lymphocytic leukemia
Am J Med
(1990) - et al.
Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia
Blood
(1989) - et al.
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome
- et al.
Philadelphia chromosome positive childhood acute lymphoblastic leukemia
Blood
(1980) - et al.
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Blood
(1992) - et al.
Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Blood
(1987) - et al.
Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia
Am J Med
(1986) - et al.
Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia
Blood
(1991) - et al.
The Philadelphia chromosome in adults presenting with acute leukemia
- et al.
Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, bcr breakpoint and prognostic significance
Leukemia
(1991)
Structural organization of the bcr gene and its role in the Ph' translocation
Nature
(1985)
The chronic myelogenous leukemia-specific p210 protein is the product of the bcr/abl hybrid gene
Science
(1986)
The molecular genetics of Philadelphia chromosome-positive leukemias
NEJM
(1988)
A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukemia
Nature
(1987)
A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia
Nature
(1987)
Cited by (104)
Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
2011, Biology of Blood and Marrow TransplantationCitation Excerpt :Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) accounts for 20%-30% of cases of adult ALL [1]. Ph+ALL is an aggressive disease with a poor prognosis, and it is not curable when treated by standard chemotherapy alone [2-5]. The results of recent clinical trials suggest that allogeneic hematopoietic stem cell transplantation (allo-HSCT) after imatinib-incorporating induction chemotherapy may be a promising option to overcome Ph+ALL [6-10].
Copyright © 1994 Published by Excerpta Medica Inc.